Search

The article presents abstracts on case reports related to adverse reactions of various drugs including abciximab, adalimumab and adenosine.

The article presents a case study of a 57-year-old man who developed allergic recurrent type III Kounis syndrome manifested as a new onset macular rash while receiving treatment with clopidogrel and abciximab for acute-onset chest pain. It notes the man had hypertension and dyslipidemia and no history of allergies.

The article presents a case study of a 64-year-old, who developed haemorrhagic transformation following treatment with abciximab for carotid artery occlusion.

The article discusses the case report of a 50-year-old woman suffering from acute coronary syndrome, who developed thrombocytopenia during treatment with abciximab.

The article presents a case study of a woman who developed thrombocytopaenia after receiving treatment with abciximab for percutaneous coronary intervention of left anterior descending artery.

The article informs that the American Association for Clinical Chemistry Annual Meeting that was held from July 15-19 in Los Angeles. California featured a presentation on hemostasis monitoring by T2 Biosystems Inc. It further informs that the presentation also focused on determining the effectiveness of anti-platelet drugs which include Aspirin and Abciximab. It mentions that the company has manufactured magnetic biosensor detector which helps in saving lives and reducing costs.

An abstract of the article "Increased airway pressure due to superior mediastinal hematoma during endovascular coiling by transcarotid approach" by P. Gupta and others is presented.

The article describes the case of thrombocytopenia that developed in a 57-year-old man during treatment with abciximab for ST-segment elevation acute coronary syndrome.

The article describes the case of intradural haematoma and paralysis that developed in a patient following treatment with abciximab for ST elevation acute coronary syndrome.

An abstract of the article "Safety of glycoprotein IIb/IIIa inhibitors in patients under therapeutic hypothermia admitted for an acute coronary syndrome," by G. Jimenez-Britez and colleagues is presented.

The article presents a case study of a 70-year-old ST-segment elevation myocardial infarction (STEMI) patient who had diagnosed with haemorrhagic pericarditis leading to cardiac tamponade after treated with abciximab.

The article presents a case study of a 64-year-old man who developed an acute non-traumatic spinal intradural extramedullary haematomas with spinal cord compression during treatment with abciximab, aspirin, heparin and prasugrel.

The article describes the case of a 53-year-old man who developed spontaneous bleeding from internal pudendal artery resulting in massive swelling in the scrotal and perineal regions while receiving multiple drugs including abciximab, clopidogrel and heparin.

An abstract of the article "Emergency reconstructive endovascular management of intraoperative complications involving the internal carotid artery from transsphenoidal surgery" by J. Griauzde and others is presented.

The article describes the case of a 41-year-old female patient who experienced ST-elevation myocardial infarction (STEMI) after undergoing placement of a paclitaxel-eluting stent. Heparin, aspirin, clopidrogel, and abciximab were given to the patient, whose angiography showed stenosis of the left descending coronary artery with an intravascular thrombus. She took oral anticoagulation in addition to clopidogrel, in which she improved along with pravastatin, atenolol, and ramipril.

The article describes the case of a 56-year-old woman who developed stent thrombosis and cerebral haemorrhage during treatment with aspirin, clopidogrel and abciximab.

The article describes the case of a patient who developed symptomatic hemorrhagic transformation after being treated with abciximab.

The article presents a case study of a 4 elderly patients with either carotid occlusion or carotid stenosis who developed fatal symptomatic intracranial haemorrhage (SICH) during treatment with abciximab.

The article presents a case study of a 75-year-old woman who suffered from alveolar haemorrhage after receiving abciximab for treatment of extensive thrombus burden.

The article discusses a study published in the October 2014 issue of "Minnesota Medicine" that investigated a case of profound thrombocytopenia that developed in a 63-year-old man following administration of abciximab.

An abstract of the article "Enterprise stent for waffle-cone stent-assisted coil embolization of large wide-necked arterial bifurcation aneurysms," by D. J. Padalino and colleagues is presented.

An abstract of the article "Undetected acute aortic dissection in a patient referred for primary coronary angioplasty: a successful treatment of perioperative bleeding after abciximab administration," by A. Arrivi and colleagues, is presented.

The article presents a case study of a 68-year-old man who developed a pulmonary haemorrhage after receiving abciximab for coronary intervention.

The article describes the case of a 65-year-old man who developed thrombocytopenia and thrombosis while being treated with abciximab.

The article describes the case of an 81-year-old man who underwent percutaneous intervention for acute left limb ischaemia and took abciximab, but suffered acute profound thrombocytopenia (APT).

The article describes the case of a 42-year-old woman who developed severe delayed thrombocytopenia following administration of abciximab during coronary angioplasty.

The article describes the case of a 68-year-old woman who developed thrombocytopenia after re-administration of abciximab.

The article describes the case of nine patients who presented with intracranial haemorrhage after neuroendovascular procedures with abciximab, referencing a study published in the August 2011 issue of the journal "Neurocritical Care."

The article describes the case of a 42-year-old man who developed acute stent thrombosis and thrombocytopenia while undergoing heparin and abciximab therapy.

The article describes the case of a 58-year-old man who experienced symptoms of hypersensitivity after receiving abciximab before percutaneous coronary intervention (PCI).

The article describes the case of a 50-year-old man with an anterior descending artery who developed thrombocytopenia while under antiplatet treatment with abciximab.

The article describes the case of a 42-year-old man who developed cardiac tamponade and coronary stent thrombosis induced by abciximab and zotarolimus therapy for acute myocardial infarction.

The article describes two cases of diffuse alveolar haemorrhage (DAH) induced by the administration of abciximab or eptifibatide for percutaneous coronary intervention (PCI). It relates the symptoms experienced by the 72-year-old woman and the 82-year-old man. The treatment administered to the patients and the outcomes are described.

The article describes the case of a 55-year-old man with an acute coronary syndrome who developed severe thrombocytopenia and alveolar haemorrhage after receiving abciximab. The patient was admitted to the intensive care unit because of chest pain. He was treated with aspirin, β-blockers, nitrates, heparin and bolus abciximab followed by a continuous infusion of abciximab. Six hours after, the patient experienced severe dyspnoea and tachypnoea. Abciximab was discontinued and the patient received platelets and packed red blood cells.

The article presents a case study of a 62-year-old man who was diagnosed with thrombocytopenia while being treated with abciximab.